Scroll to explore
Our product areas
Our broad vaccines portfolio targets infectious diseases at every stage of life, helping to protect people from meningitis, shingles, RSV, flu, polio and many more. Our portfolio of more than 20 marketed vaccines is one of the industry’s broadest. We deliver over 1.5 million doses of our vaccines every day; and 4 out of 10 infants born each year receive at least one GSK vaccine. Our vaccines portfolio targets infectious diseases at every stage of life, helping to protect people from RSV, meningitis, shingles, flu, polio and many more.
Specialty medicines are prescribed by specialist healthcare practitioners. Our portfolio of specialty medicines prevents and treats diseases, from HIV to respiratory diseases, immune-mediated conditions like lupus, and cancer. Many are first or best-in-class. Our specialty medicines is focused on four therapeutic areas: infectious diseases, HIV, respiratory/immunology and oncology. We’re leaders in infectious diseases and HIV innovation and we’re building our positions in immunology and oncology.
General medicines are usually prescribed in primary care or community settings by general healthcare practitioners. General medicines include our inhaled medicines for asthma and COPD, antibiotics and medicines for skin diseases, in a portfolio which includes pre-launch R&D assets, growth and established products. Every day, our general medicines improve health and make life better for millions all over the world and our portfolio of more than 150 primary care products supplied in 112 countries worldwide.
Our vaccines and medicines
Getting ahead means preventing disease as well as treating it. Our R&D focus is to deliver new vaccines and medicines using the science of the immune system and advanced technologies to impact health at scale.
Explore our innovation stories